These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19852983)

  • 41. Selected Milestones in Antiviral Drug Development.
    De Clercq E
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antiviral drugs].
    Denys A
    Pol Merkur Lekarski; 2011 May; 30(179):359-61. PubMed ID: 21675143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curious discoveries in antiviral drug development: the role of serendipity.
    De Clercq E
    Med Res Rev; 2015 Jul; 35(4):698-719. PubMed ID: 25726922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
    De Clercq E
    Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.
    De Clercq E
    Adv Virus Res; 1993; 42():1-55. PubMed ID: 8430518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The history and progress of antiviral research].
    Baba M
    Nihon Rinsho; 2012 Apr; 70(4):553-7. PubMed ID: 22568133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Advances in antiviral chemotherapy].
    Baba M
    Uirusu; 2005 Jun; 55(1):69-75. PubMed ID: 16308532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel approaches to inhibiting HIV-1 replication.
    Adamson CS; Freed EO
    Antiviral Res; 2010 Jan; 85(1):119-41. PubMed ID: 19782103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A scientific career from the early 1960s till 2023: A tale of the various protagonists.
    De Clercq E
    Biochem Pharmacol; 2024 Oct; 228():116248. PubMed ID: 38701868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acyclic nucleoside phosphonates: a new dimension to the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    J Med Microbiol; 1998 Jan; 47(1):1-3. PubMed ID: 9449944
    [No Abstract]   [Full Text] [Related]  

  • 51. Highlights in the development of new antiviral agents.
    De Clercq E
    Mini Rev Med Chem; 2002 Apr; 2(2):163-75. PubMed ID: 12370077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydrogen Bonding (Base Pairing) in Antiviral Activity.
    De Clercq E
    Viruses; 2023 May; 15(5):. PubMed ID: 37243232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation).
    Clercq E
    Antivir Chem Chemother; 2022; 30():20402066221129979. PubMed ID: 36305032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The novel antiviral pipeline to treat severe neonatal viral infections.
    Kadambari S; Griffiths PD; Sharland M
    Pediatr Infect Dis J; 2013 Jun; 32(6):682-3. PubMed ID: 23435310
    [No Abstract]   [Full Text] [Related]  

  • 55. Antiviral drug development--success and failure: a personal perspective with a Japanese connection.
    De Clercq E
    Antivir Chem Chemother; 2013 May; 23(2):45-55. PubMed ID: 22992351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oligonucleotides and polyribonucleotides: a review of antiviral activity.
    Markosian M; Hyde RM
    Antivir Chem Chemother; 2005; 16(2):91-102. PubMed ID: 15889532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Introduction to a special issue on viral infections in the elderly].
    Nihon Ronen Igakkai Zasshi; 2021; 58(1):47. PubMed ID: 33627560
    [No Abstract]   [Full Text] [Related]  

  • 58. Editorial on special issue on "Immunobiology of Viral Infections".
    Baldauf HM; Volz A
    Med Microbiol Immunol; 2023 Apr; 212(2):123-124. PubMed ID: 36991263
    [No Abstract]   [Full Text] [Related]  

  • 59. Mitotherapy inhibits against tenofovir induced nephrotoxicity on rat renal proximal tubular cells.
    Hosseini MJ; Hassanbeigloo A; Abbasi H; Arjmand A; Sherkat F; Pourahmad J
    Biochem Biophys Rep; 2024 Jul; 38():101669. PubMed ID: 38434141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies.
    Jbara-Agbaria D; Blondzik S; Burger-Kentischer A; Agbaria M; Nordling-David MM; Giterman A; Aizik G; Rupp S; Golomb G
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.